DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

Notice on Convening the 2nd Extraordinary General Meeting in 2025

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Release

Notice on Convening the 2nd Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases